Health
New initiative identifies key parameters underlying effective anti-tumor immunity – News-Medical.Net
Neoantigens, tiny markers that arise from cancer mutations, flag cells as cancerous and could be the key to unlocking a new generation of immunotherapies.
Reviewed by Emily Henderson, B.Sc.Oct 9 2020
Neoantigens, tiny markers that arise from cancer mutations, flag cells as cancerous and could be the key to unlocking a new generation of immunotherapies. Targeting the “right” neoantigens – in a cancer vaccine or a cell therapy – has the promise to eliminate a patient’s cancer with minimal side effects. But hundreds of mutations can exist in a tumor, and only some can give rise to neoantigens that can trigger an immune response against cancer. The q…
-
Noosa News23 hours agoItalian Film Festival, Brisbane: All the Details
-
Noosa News18 hours agoKatter and pregnant wife crash-land plane in outback Qld
-
Noosa News18 hours agoFollowing Up Hottest 100 of Australian Songs Success with a Second Documentary About Your Life and Career: Jimmy Barnes Talks ‘Working Class Man’
-
Business19 hours ago16 ASX 200 shares roar to multi-year highs amid new market milestone